Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up studyShow others and affiliations
2010 (English)In: Diabetes & Metabolism, ISSN 1262-3636, E-ISSN 1878-1780, Vol. 36, no 2, p. 137-143Article in journal (Refereed) Published
Abstract [en]
Aim. Plasma total adiponectin is a marker of insulin resistance, but its role in predicting cardiovascular events is unclear. We aimed to investigate the role of adiponectin as a predictor of cardiovascular risk in middle-aged men, and to describe the association between adiponectin and glucose metabolism.
Methods. In this population-based prospective study of middle-aged men (n=3885), total adiponectin was analyzed. All individuals had undergone an oral glucose tolerance test (OGTTs), and the mean follow-up duration was 27 years. Regression analyses were carried out for indices of glucose metabolism in relation to quintiles (Q1-Q5) of total aliponectin levels. After stratification for smoking or not, the association between total adiponectin and the first incidence of fatal or non-fatal cardiovascular disease (CVD) was analyzed, using Cox's proportional-hazards regression model.
Results. In a separate multiple-regression analysis and after adjusting for possible confounders, the relationship between adiponectin levels and markers of glucose metabolism were found to be significant (P<0.05). However, adiponectin did not independently predict the risk of stroke, coronary events, or a combination of these two outcomes.
Conclusion. Levels of total plasma adiponectin are not useful for predicting long-term cardiovascular events in middle-aged men, but are strongly associated with glucose metabolism and markers of insulin resistance. (c) 2010 Elsevier Masson SAS. All rights reserved.
Place, publisher, year, edition, pages
2010. Vol. 36, no 2, p. 137-143
Keywords [en]
Adiponectin, Cardiovascular events, Coronary events, Glucose metabolism, Stroke, Prospective study, Long-term
National Category
Medical and Health Sciences
Research subject
Medicine
Identifiers
URN: urn:nbn:se:oru:diva-26692DOI: 10.1016/j.diabet.2009.10.004ISI: 000277835800007Scopus ID: 2-s2.0-77953286453OAI: oai:DiVA.org:oru-26692DiVA, id: diva2:578301
Note
Payam Khalili is also affiliated to Cent Hosp Karlstad, Dept Internal Med, S-65230 Karlstad, Sweden
J. Jendle is also affiliated to Cent Hosp Karlstad, Dept Internal Med, S-65230 Karlstad, Sweden
Peter M. Nilsson is also affiliated to Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden
2012-12-182012-12-182023-12-08Bibliographically approved
In thesis